Top U.S. health officials were concerned with an “adverse event issue” concerning COVID-19 vaccines being injected during pregnancy, according to newly disclosed emails.
On May 14, 2021, officials with the U.S. Food and Drug Administration (FDA) and U.S. Centers for Disease Control and Prevention (CDC) were exchanging emails about language concerning the co-administration of COVID-19 vaccines with other vaccines during pregnancy.
“Please let me know if you want to connect about the adverse event issue later today. Seems like work is still ongoing, but let me know,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, wrote to colleagues at both agencies.
Dr. Amanda Cohn, chief medical officer of the CDC’s National Center for Immunizations and Respiratory Diseases, replied.
“We have a meeting with Rochelle at 3:30 about if we should say anything or wait until we have more definitive information … I will let you know where we land,” Cohn wrote. Dr. Rochelle Walensky is the head of the CDC.